Le Lézard
Classified in: Health
Subject: SVY

Global Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017


LONDON, Nov. 16, 2017 /PRNewswire/ -- Fore Pharma announced the results of its Bipolar Disorder patients study in a new report 'Global Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017'.

Download the full report: https://www.reportbuyer.com/product/3895235

The report provides insights into Bipolar Disorder epidemiology, Bipolar Disorder diagnosed patients, and Bipolar Disorder treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Bipolar Disorder derived from epidemiological analysis, percentage of patients diagnosed with Bipolar Disorder, and percentage of patients treated with a therapy.

The study helps executives estimate Bipolar Disorder market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Bipolar Disorder prevalence, Bipolar Disorder diagnosis rate, and Bipolar Disorder treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:
- Bipolar Disorder Patient Flow
- Bipolar Disorder Prevalence
- Bipolar Disorder Diagnosed Patients
- Bipolar Disorder Treated Patients

Download the full report: https://www.reportbuyer.com/product/3895235

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer


These press releases may also interest you

at 02:24
Today, 23 April 2024, the subscription period in SciBase Holding AB (publ) ('SciBase' or the 'Company') rights issue of units of up to approximately SEK 15 million commences (the 'Rights Issue'). The Rights Issue was resolved by the Board of...

at 02:05
Antech, the veterinary diagnostics company focused on partnering with veterinary professionals to predict, diagnose, and monitor wellness and disease, today announced the launch of the breakthrough in-hospital Nu.Q® Canine Cancer Test in Europe. A...

at 02:00
Red Arrow Therapeutics Inc. closed a $4.5M Seed Extension round, raising from four, top-tier institutional investors in Japan. Participants of this round are: Beyond Next Ventures Inc.The University of Tokyo Edge Capital Partners Co., Ltd.Keio...

at 01:05
Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care...

at 01:01
Allied Market Research published a report, titled, "Electroceuticals/Bioelectric Medicine Market by Product (Cardiac Pacemakers and Implantable Cardioverter Defibrillators, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus...

at 00:49
Allied Market Research published a report, titled, "Inhaled Nitric Oxide Market by Application (Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease, Acute Respiratory Distress Syndrome, and Others): Global Opportunity Analysis and...



News published on and distributed by: